Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer

Heymach John V., Johnson Bruce E., Prager Diane, Csada Edit, Roubec Jaromír, Pešek Miloš, Špásová Irena, Belani Chandra P., Bodrogi István, Gadgeel Shirish, Kennedy Sarah J., Hou Jennie, Herbst Roy S.
2007

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Wu Yi-Long, Tsuboi Masahiro, He Jie, John Thomas, Grohe Christian, Majem Margarita, Goldman Jonathan W., Laktionov Konstantin, Kim Sang-We, Kato Terufumi, Vu Huu-Vinh, Lu Shun, Lee Kye-Young, Akewanlop Charuwan, Yu Chong-Jen, de Marinis Filippo, Bonanno Laura, Domine Manuel, Shepherd Frances A., Zeng Lingmin, Hodge Rachel, Atasoy Ajlan, Rukazenkov Yuri, Herbst Roy S., Kollaborációs szervezet: ADAURA Investigators, Somfay Attila, et al
2020